Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response ; volume:14 ; number:1 ; day:13 ; month:5 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (13.5.2024), 1-12, 12.2024
- Urheber
-
Chida, Takeshi
Ohta, Kazuyoshi
Noritake, Hidenao
Matsushita, Masahiro
Murohisa, Gou
Kageyama, Fujito
Sasada, Yuzo
Oyaizu, Tatsuki
Tsugiki, Minoru
Tamakoshi, Katsutoshi
Nakajima, Takeyuki
Suda, Takafumi
Kawata, Kazuhito
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-61366-y
- URN
-
urn:nbn:de:101:1-2407222106517.713331123127
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chida, Takeshi
- Ohta, Kazuyoshi
- Noritake, Hidenao
- Matsushita, Masahiro
- Murohisa, Gou
- Kageyama, Fujito
- Sasada, Yuzo
- Oyaizu, Tatsuki
- Tsugiki, Minoru
- Tamakoshi, Katsutoshi
- Nakajima, Takeyuki
- Suda, Takafumi
- Kawata, Kazuhito
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Hepatitis delta: virological and clinical aspects
Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Hepatitis delta: virological and clinical aspects
Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Hepatitis delta: virological and clinical aspects